Ocuco Invests in Ocumetra to Integrate Myopia Analytics into Practice Management Software

Ocuco announced a minority investment in Ocumetra, a data science company for eyecare. As part of the deal, Ocuco CEO Leo Mac Canna joined Ocumetra’s board, and Ocumetra’s machine learning tools will integrate with Ocuco’s next-generation cloud-hosted Practice Management Software. Ocumetra offers nine clinical tools, including the Refractogram for myopia treatment efficacy analytics. Founded in 2020 by Professors James Loughman and Ian Flitcroft, the company aims to support eye care professionals with evidence-based decision tools derived from over one million eyes globally. While some products were slated for early 2022 launch, others are classified as software-as-a-medical-device, requiring regulatory approvals such as ISO13485, CE mark, and FDA clearance.